http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0725785-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9051cdae59d32aa5ab588a63df61b3da |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-06 |
| filingDate | 1994-10-26^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1997-07-23^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc54edc37cae51d72920e21f5a7945dd |
| publicationDate | 1997-07-23^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0725785-B1 |
| titleOfInvention | Process for the preparation of rufloxacin and salts thereof |
| abstract | PCT No. PCT/EP94/03512 Sec. 371 Date Apr. 24, 1996 Sec. 102(e) Date Apr. 24, 1996 PCT Filed Oct. 26, 1994 PCT Pub. No. WO95/11907 PCT Pub. Date May 4, 1995A process for the preparation of rufloxacin, a compound of the formula I <IMAGE> and salts thereof is described. This is effected by reducing a quinoline disulfide of formula (II) as herein defined, and subjecting the resulting 2-mercaptoethyl quinoline of formula (III) as herein defined to a cyclization in a basic medium and hydrolyzing the rufloxacin ester thus obtained and, if desired, forming the salts thereof. |
| priorityDate | 1993-10-27^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 73 of 73.